retatrutide mechanism clinical data Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) The Effect of Retatrutide on

These medications improve insulin secretion, suppress glucagon, and slow gastric emptying

The cannabinoid hyperemesis syndrome (CHS) is a distinct syndrome, related to cyclic vomiting syndrome, characterized by recurrent vomiting associated with abdominal pain, hypothermia and compulsive hot bathing in the setting of chronic cannabinoid use [212,213]

The Bridge covers certain FDA-approved GLP-1 medications prescribed for weight management

FDA Guidelines for GLP-1 Medications The FDA has clear criteria for prescribing GLP-1 medications for chronic weight management: a BMI of 30 or higher, or a BMI of 27 with at least one weight-related comorbidity